Services on Demand
- Cited by SciELO
- Access statistics
- Similars in SciELO
Print version ISSN 0365-0596
An. Bras. Dermatol. vol.86 no.5 Rio de Janeiro Sept./Oct. 2011
Localized primary cutaneous nodular amyloidosis - case report*
Januário de Souza JúniorI; Renata Almeida SchettiniI; Walquíria Lima TupinambáI; Antonio Pedro Mendes SchettiniII; Carlos Alberto Rodrigues ChiranoIII; Cesare MassoneIV
IResident Physician in Dermatology, Alfredo da Matta Foundation (Fundação Alfredo da Matta - FUAM) - Manaus (AM), Brazil
IIMaster's degree in Tropical Pathology, Federal University of the Amazon (Universidade Federal do Amazonas - UFAM) - Dermatologist physician, Preceptor of Medical Residency in Dermatology, Alfredo da Matta Foundation (Fundação Alfredo da Matta - FUAM) - Manaus (AM), Brazil
IIIDermatology Specialist by the Federal University of the Amazon (Universidade Federal do Amazonas - UFAM)- Dermatologist physician, Preceptor of Medical Residency in Dermatology, Alfredo da Matta Foundation (Fundação Alfredo da Matta - FUAM) - Manaus (AM), Brazil
IVPhD in Dermatology - Dermatologist physician, Associate Professor of the Dermatology Department, University of Graz - Graz, Austria
Amyloidosis results from deposition of fibrous and insoluble amyloid protein in extracellular spaces of organs and tissues. Amyloid deposition can be localized or systemic and either primary or secondary. We report a case of localized primary cutaneous nodular amyloidosis manifested by papular-nodular, reddish-brown lesions affecting the nasal area, without evidence of systemic involvement. Immunohistochemistry showed the presence of immunoglobulin kappa light chain.
Keywords: Amyloidosis; Plasma cells; Skin
Amyloidosis is a generic term used for a group of diseases characterized by deposition of a substance chiefly composed of fibrous protein, called amyloid, which may produce compression and/or dysfunction of several organs, among them the skin. These diseases may be divided into systemic or localized forms. The localized forms may be primary or secondary. The primary cutaneous forms include macular amyloidosis, lichen amyloidosis and nodular or tumefactive amyloidosis. Systemic amyloidosis can be primary, hereditary or not, secondary to chronic inflammatory diseases or neoplasias and be associated with hemodialysis. The distinction between primary localized cutaneous amyloidosis and the systemic forms should be made through a careful physical examination and supplementary tests to rule out the presence of extracutaneous amyloid deposits and/or plasmacyte dyscrasias.1,2,3
We present a case of primary cutaneous nodular amyloidosis localized on the nose. Immunohistochemical screening demonstrated mainly the presence of immunoglobulin kappa chains close to groups of plasmacytes. The patient did not demonstrate any systemic involvement signs in a oneyear follow-up. This disease should always be considered in differential diagnosis of papulous or nodular face lesions.4
A male, 39-year-old patient referred the onset of nose lesions for a period of 2 years. He denied relevant pathological antecedents. Upon examination, erythematous papulonodular lesions were observed in groups on the top of the nose and right nasal wing (Figure 1).
A cutaneous biopsy was performed and the histopathological exam revealed rectified epidermis and masses of eosinophilic amorphous material occupying the entire extension of the dermis, with compression of cutaneous adnexa and surrounding vessels (Figures 2 and 3). Congo-red staining revealed a mass of orange amorphous material occupying the dermis and hypodermis diffusely; the diagnosis of cutaneous amyloidosis was made. The immunohistochemical screening performed at the Dermatology Departament, University of Graz (Austria) with the immunoperoxidase technique, using monoclonal antibodies from Dako laboratory (Glostrup-Denmark) showed strongly positive immune marking for immunoglobulin kappa chain and with less intensity for lambda chain. It also demonstrated plasmacyte clones infiltrate around the vessels (Figures 4 and 5). Immune marking for cytokeratins was negative (Figure 6). The supplementary tests: hemogram, lipid profile, liver and kidney function, 24-hour proteinuria, protein electrophoresis, urinalysis type I, antinuclear factor, rheumatoid factor, HIV and B and C serologies did not show abnormalities. The patient is being followed at the outpatient clinic (clinical and laboratory evaluation twice a year), without any evidence of systemic involvement. The lesions will be surgically removed.
Localized primary cutaneous nodular amyloi-dosis is the rarest cutaneous presentation of amyloidosis. It is characterized by the diffuse deposition of amyloids in the dermis, subcutaneous tissue and small vessels in the dermis. The amyloid substance deposited is of the AL type, which is also found in primary systemic amyloidosis and in the form associated with multiple myeloma, composed of immunoglobulin light, kappa and lambda chains. It is considered a form of extramedullary plasmacytoma.5
The patients present asymptomatic nodules or plaques, single or multiple, rose-brown in color with a tendency to involve the face, mainly the nose and periauricular areas, genitals, trunk and limbs. These lesions are similar to those found in primary systemic amyloidosis associated with lymphoproliferative plasmacytary disease.6
It occurs equally in both genders, with mean age at diagnosis of 60.8 years. The diagnosis of the disease is often late and the mean time from onset of lesions to diagnosis is 13.5 years.5
The diagnosis is established through skin biopsy, when a diffuse deposit of amyloid substance is observed subcutaneously in the dermis, on the walls of small vessels. A plasmacyte infiltrate is also found in perivascular disposition. The amyloid substance is better visualized in routine Congo-red staining and immunohistochemistry reveals monoclonal plasma-cytes and immunoglobulin kappa and lambda chains.4,7 Cytokeratins are not present.8 The process may have a chronic, localized and benign course, but the patients must be monitored regarding progression to systemic amyloidosis and plasmacyte dyscrasias, which occur in 7 to 50% of patients.7,9 There are reports of association with Sjögren syndrome and diabetes mellitus. The clinical lesions, the demonstration of amyloid substance by Congo-red staining and the presence of monoclonal chains of immunoglobulin light chains, mainly κappa, found in the studied case, favors the hypothesis of type AL, that includes the nodular variant of the localized primary cutaneous form, primary systemic amyloidosis and systemic secondary amyloidosis associated with multiple myeloma, monoclonal gammopathy or plasmacytary discrasia.7 As no systemic alterations were detected, the final diagnosis was localized primary cutaneous nodular amyloidosis. The fact that there was no evidence of deposition of cytokeratin filaments rules out other clinical forms of cutaneous amyloidosis. The patient is being monitored regarding progression to systemic amyloidosis and the presence of plasmacytary discrasias. Although all forms of treatment present a high rate of local recurrence, a joint decision was made with the patient for surgical excision of lesions to improve his physical appearance. 10, 11
1. Roselinno AMF. Doenças de origem metabólica e nutricional. In: Ramos e Silva M, Castro MCR. Fundamentos de Dermatologia. Rio de Janeiro: Editora Atheneu; 2009. p.1099. [ Links ]
2. Sampaio S, Rivitti E. Amiloidoses. In: Sampaio S, Rivitti E. Dermatologia. São Paulo: Artes Médicas; 2007. p.896-899. [ Links ]
3. Criado PR, Silva CS, Vasconcellos C, Valente NYS, Maito JB. Extensive nodular cutaneous amyloidosis: an unusual presentation. J Eur Acad Dermatol Venereol. 2005;19:481-3. [ Links ]
4. Fuenzalida H, Valenzuela F, Misad C. Nodular amyloidosis: two clinical case reports. Clin Exp Dermatol. 2008;34:92-4. [ Links ]
5. Tarun N, Sunil D, Sanjeev H, Bishan Dass R. Nodule in the nasolabial fold. Indian J Dermatol Venereol Leprol. 2008;74:299. [ Links ]
6. Breatmatch SM. Amyloid and the amyloidoses of the skin. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook's Textbook of Dermatology. United Kingdom: Wiley-Blackwell; 2010. p.42-59. [ Links ]
7. Valera FCP, Fomin DS, Maggioni Jr GC, Grellet M. Amiloidose localizada laríngea: relato de caso e revisão de literatura. Rev Bras Otorrinolaringol. 2004;70:423-6. [ Links ]
8. Kalajian A, Waldman M, Knable A. Nodular primary localized cutaneous amyloidosis after trauma: a case report and discussion of the rate of progression to systemic amyloidosis. J Am Acad Dermatol. 2007;57(2 Suppl):S26-9. [ Links ]
9. Chotzen V, Gandour-Edwards R, Zang M, Vogt P. Long-term AL primary amyloidosis. A case report. Dermatol Online J. 1995;2:15. [ Links ]
10. Koh M, Kwok CY-K, Tan H-W, Mancer JFK. A rare case of primary cutaneous nodular amiloidosis of the face. J Eur Acad Dermatol Venereol. 2008;22:1011-2. [ Links ]
11. Melo LV, Reis VMS, Criado PR, Müller H, Valente NYS. Amiloidose sistêmica associada a mieloma múltiplo: relato de caso com amiloidose cutânea exuberante. An Bras Dermatol. 1997;72:151-4. [ Links ]
Mailing address: Received on 17.07.2010. * Study carried out at the Tropical Dermatology and Venereology Foundation "Alfredo da Matta" (FUAM) - Manaus (AM), Brazil.
Renata Almeida Schettini
Rua Codajás, n. 24 - Cachoeirinha
69065-130 Manaus, AM, Brazil
Approved by the Advisory Board and accepted for publication on 26.08.2010.
Conflict of interest: None
Financial funding: None
Received on 17.07.2010.
* Study carried out at the Tropical Dermatology and Venereology Foundation "Alfredo da Matta" (FUAM) - Manaus (AM), Brazil.